Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

140 ARTÍCULOS , VIENDO DEL 76 AL 90

Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology

Ishii M, Iadecola C.

Cell Metab. 2015 Nov 3;22(5):761-76. doi: 10.1016/j.cmet.2015.08.016. Epub 2015 Sep 10.

LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention

Dias HK, Brown CL, Polidori MC, Lip GY, Griffiths HR.

Clin Sci (Lond). 2015 Dec;129(12):1195-206. doi: 10.1042/CS20150351. Epub 2015 Sep 23.

Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models

Kincses ZT, Király A, Veréb D, Vécsei L.

J Alzheimers Dis. 2015;47(2):277-90. doi: 10.3233/JAD-143195.

Biomarkers in Sporadic and Familial Alzheimer's Disease

Lista S, O'Bryant SE, Blennow K, Dubois B, Hugon J, Zetterberg H, Hampel H.

J Alzheimers Dis. 2015;47(2):291-317. doi: 10.3233/JAD-143006.

Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject

Tiepolt S, Patt M, Hoffmann KT, Schroeter ML, Sabri O, Barthel H.

J Alzheimers Dis. 2015;47(3):539-43. doi: 10.3233/JAD-150163.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

A Novel Plasma Based Biomarker of Alzheimer's Disease

Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA.

J Alzheimers Dis. 2015;47(3):761-71. doi: 10.3233/JAD-150183.

Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease

Catania M, Di Fede G, Tonoli E, Benussi L, Pasquali C, Giaccone G, Maderna E, Ghidoni R, Tagliavini F.

J Alzheimers Dis. 2015;47(4):877-81. doi: 10.3233/JAD-150179.

Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau

Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J.

J Alzheimers Dis. 2015;47(4):883-7. doi: 10.3233/JAD-150420.

Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting

Weise D, Tiepolt S, Awissus C, Hoffmann KT, Lobsien D, Kaiser T, Barthel H, Sabri O, Gertz HJ.

J Alzheimers Dis. 2015;48(2):425-32. doi: 10.3233/JAD-150229.

Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

Sarlus H, Eyjolfsdottir H, Eriksdotter M, Oprica M, Schultzberg M.

J Alzheimers Dis. 2015;48(2):495-505. doi: 10.3233/JAD-143147.

Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions

Raskin J, Cummings J, Hardy J, Schuh K, Dean RA.

Curr Alzheimer Res. 2015;12(8):712-22. doi: 10.2174/1567205012666150701103107.

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers

Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.

PLoS One. 2015 Oct 1;10(10):e0139233. doi: 10.1371/journal.pone.0139233. eCollection 2015.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias